Publisher Correction: Single-cell Transcriptomic Analysis Suggests Two Molecularly Distinct Subtypes of Intrahepatic Cholangiocarcinoma

Overview

Journal Nat Commun

Specialty Biology

Date 2022 May 17

PMID 35581192

Authors

Guohe Song

Yang Shi

Lu Meng

Jiaqiang Ma

Siyuan Huang

Juan Zhang

Yingcheng Wu

Jiaxin Li

Youpei Lin

Shuaixi Yang

Dongning Rao

Yifei Cheng

Jian Lin

Shuyi Ji

Yuming Liu

Shan Jiang

Xiaoliang Wang

Shu Zhang

Aiwu Ke

Xiaoying Wang

Ya Cao

Yuan Ji

Jian Zhou

Jia Fan

Xiaoming Zhang

Ruibin Xi

Qiang Gao

Affiliations

Soon will be listed here.

Citing Articles

Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.

Cost-effectiveness of trastuzumab deruxtecan as a second-line treatment for HER2-mutant advanced non-small cell lung cancer.

Cai Q, You S, Huang J, Gong C, Zhang W, Zhou A Hum Vaccin Immunother. 2025; 21(1):2468070.

PMID: 39989197 PMC: 11853545. DOI: 10.1080/21645515.2025.2468070.

Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice.

Chen S, Huang C, Huang C, Li K, Cheng M, Zhang C J Clin Invest. 2025; 135(5).

PMID: 39774471 PMC: 11870738. DOI: 10.1172/JCI180893.

SPP1 is a plasma biomarker associated with the dia gnosis and prediction of prognosis in sepsis.

Shen Y, Xiong W, Hu Y, Zhong W Sci Rep. 2024; 14(1):27205.

PMID: 39516332 PMC: 11549466. DOI: 10.1038/s41598-024-78420-4.

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Park R, Parikh M, Pappas L, Sade-Feldman M, Kulkarni A, Bi L medRxiv. 2024; .

PMID: 39417106 PMC: 11483019. DOI: 10.1101/2024.10.08.24315092.